BCG Vaccine Market Expected to Grow Rapidly by 2023
The BCG vaccine market is estimated to reach $28,051 thousand by 2023, growing at a CAGR of 4.6% from 2017 to 2023. The Indian BCG vaccines market holds the highest share in the global BCG vaccines market.
Get sample copy: https://goo.gl/oHbpbY
The BCG vaccine market is estimated to reach $28,051 thousand by 2023, growing at a CAGR of 4.6% from 2017 to 2023. The Indian BCG vaccines market holds the highest share in the global BCG vaccines market.
Get sample copy: https://goo.gl/oHbpbY
BCG Vaccine Market BCG Vaccine Market by Demographics [Pediatrics (0-18 Years) and Adults (19-35 Years)] - Global Opportunity Analysis and Industry Forecast, 2017-2023
- Page 2 and 3: BCG Vaccine Market Introduction •
- Page 4 and 5: BCG Vaccine Market Market Segments
- Page 6: “ A report titled “BCG vaccine
<strong>BCG</strong> <strong>Vaccine</strong> <strong>Market</strong><br />
<strong>BCG</strong> <strong>Vaccine</strong> <strong>Market</strong> <strong>by</strong> Demographics [Pediatrics (0-18 Years) and Adults (19-35<br />
Years)] - Global Opportunity Analysis and Industry Forecast, 2017-<strong>2023</strong>
<strong>BCG</strong> <strong>Vaccine</strong> <strong>Market</strong><br />
Introduction<br />
• Bacillus Calmette-Gurin (<strong>BCG</strong>) vaccine is the only vaccine currently available for<br />
prevention of tuberculosis (TB). One dose of <strong>BCG</strong> vaccine is recommended for healthy<br />
babies at birth in countries where tuberculosis is common.
<strong>BCG</strong> <strong>Vaccine</strong> <strong>Market</strong><br />
Fac<strong>to</strong>rs Contributing <strong>to</strong> <strong>Market</strong> <strong>Grow</strong>th<br />
• The major fac<strong>to</strong>r that contributes <strong>to</strong> the market growth are increase in incidence rate<br />
of tuberculosis in developing nations, rise in R&D activities related <strong>to</strong> vaccines, and<br />
growth in government initiatives and focus on immunization programs globally.
<strong>BCG</strong> <strong>Vaccine</strong> <strong>Market</strong><br />
<strong>Market</strong> Segments
<strong>BCG</strong> <strong>Vaccine</strong> <strong>Market</strong><br />
Leading Players<br />
• The list of key players profiled in this report include Merck & Co., Inc., Sanofi Pasteur,<br />
Japan <strong>BCG</strong> Labora<strong>to</strong>ry, China National Biotec Group (a subsidiary of China National<br />
Pharmaceutical Group Corporation), Serum Institute of India Pvt. Ltd., InterVax Ltd.,<br />
GreenSignal Bio Pharma Limited (GSBPL), and Statens Serum Institut.
“<br />
A report titled “<strong>BCG</strong> vaccine market- Opportunities and Forecasts, 2017 – <strong>2023</strong>”<br />
has been recently published <strong>by</strong> Allied <strong>Market</strong> Research. It makes an in-depth<br />
analysis of current trends, drivers, and restraining fac<strong>to</strong>rs that affect financial<br />
ratios relevant <strong>to</strong> the industry. Company profiles for key vendors in business builds<br />
a comprehensive picture of profitable opportunities from stakeholder’s<br />
perspective.<br />
”<br />
To know more about the <strong>BCG</strong> vaccine market- Opportunities and Forecasts, 2017 – <strong>2023</strong> report:<br />
https://www.alliedmarketresearch.com/<strong>BCG</strong>-vaccine-market<br />
Follow us on<br />
Thank You
Change language